Announcement of Fujian Aonong Biotechnology Group Co., Ltd. on receipt of notification of filing of case from China Securities Regulatory Commission

Securities code: 603363 Securities abbreviation: Aonong Biotechnology Announcement number: 2026-028

Fujian Aonong Biotechnology Group Co., Ltd.

Announcement on receipt of notification of filing of case from China Securities Regulatory Commission

The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.

Fujian Aonong Biotechnology Group Co., Ltd. (hereinafter referred to as the "Company") received the "Notification of Case Filing" (No.: Securities Regulatory Commission Filing No. 0262026004) issued by the China Securities Regulatory Commission (hereinafter referred to as the "China Securities Regulatory Commission") on April 22, 2026. Because the company was suspected of violating laws and regulations in information disclosure, the China Securities Regulatory Commission decided to file a case against the company in accordance with the Securities Law of the People's Republic of China, the Administrative Punishment Law of the People's Republic of China and other laws and regulations.

During the investigation period, the company will actively cooperate with the investigation of the China Securities Regulatory Commission and strictly fulfill its information disclosure obligations in accordance with relevant laws, regulations and regulatory requirements. All the company's information is based on the information published on the Shanghai Stock Exchange website (www.sse.com.cn) and other company-designated media. Investors are kindly requested to invest rationally and pay attention to investment risks.

Announcement is hereby made.

Board of Directors of Fujian Aonong Biotechnology Group Co., Ltd.

April 23, 2026